“Why Europe?”: Lia Koraki on Europe’s Strengths in Clinical Research
As part of the “Why Europe?” campaign by the European CRO Federation (EUCROF), Evangelia (Lia) Koraki, President of HACRO – Hellenic Association of CROs and member of the EUCROF Executive Board, highlighted Europe’s key strengths in clinical research.
“Europe combines world-class science, experienced investigators, advanced research centres and diverse patient populations. Strong standards for quality and patient safety provide a trusted environment for clinical research. Europe has what it takes to lead in global clinical research, and CROs have a key role in making it happen. Choose Europe.”
Evangelia (Lia) Koraki, President of HACRO
To support this vision, EUCROF promotes high-quality clinical research across Europe by advancing the skills, expertise and regulatory standards of CROs. It represents CRO interests before European regulatory bodies, pharmaceutical companies and the wider clinical research community.
Across the continent’s diverse healthcare systems, CROs accelerate the development of safe and effective new treatments by navigating multi-country regulations, managing patient recruitment and ensuring strict data quality.



